# Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis

**Authors:** Ji Eun Lee, Taejun Yoon, Sang-Won Lee, Sung Soo Ahn

PMC · DOI: 10.1038/s41598-024-59484-8 · Scientific Reports · 2024-04-15

## TL;DR

This study found that certain chemokine levels in blood correlate with disease activity in patients with MPA and GPA, with CX3CL1 being a strong predictor of active disease.

## Contribution

The study identifies CX3CL1 as a novel biomarker for predicting active disease in MPA/GPA patients.

## Key findings

- CCL4, CXCL1, and CX3CL1 levels correlate with disease activity in MPA/GPA patients.
- CX3CL1 levels above 2408.92 pg/mL strongly predict active disease.
- Strong correlations exist between several chemokine pairs in patient sera.

## Abstract

We evaluated chemokine expression and its correlation with disease activity in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) (MPA/GPA). Serum CCL2, CCL4, CCL19, CXCL1, CXCL2, and CX3CL1 level in 80 patients were analysed using multiple enzyme-linked immunosorbent assays. Correlations between variables were investigated using Pearson’s correlation analysis, and receiver operator curve analysis was performed to identify optimal CX3CL1 values in determining active disease. Multivariate logistic regression analysis was done to evaluate predictors of active disease. CCL4 (r = 0.251, p = 0.025), CXCL1 (r = 0.270, p = 0.015), and CX3CL1 (r = 0.295, p = 0.008) significantly correlated with BVAS, while CX3CL1 was associated with five-factor score (r =  − 0.290, p = 0.009). Correlations were revealed between CCL2 and CCL4 (r = 0.267, p = 0.017), CCL4 and CXCL1 (r = 0.368, p < 0.001), CCL4 and CXCL2 (r = 0.436, p < 0.001), and CXCL1 and CXCL2 (r = 0.518, p < 0.001). Multivariate analysis revealed serum CX3CL1 levels > 2408.92 pg/mL could predict active disease (odds ratio, 27.401, p < 0.001). Serum chemokine levels of CCL4, CXCL1, and CX3CL1 showed association with disease activity and especially, CX3CL1 > 2408.92 pg/mL showed potential in predicting active MPA/GPA.

## Linked entities

- **Proteins:** CCL2 (C-C motif chemokine ligand 2), CCL4 (C-C motif chemokine ligand 4), CCL19 (C-C motif chemokine ligand 19), CXCL1 (C-X-C motif chemokine ligand 1), CXCL2 (C-X-C motif chemokine ligand 2), CX3CL1 (C-X3-C motif chemokine ligand 1)
- **Diseases:** microscopic polyangiitis (MONDO:0019124), granulomatosis with polyangiitis (MONDO:0012105)

## Full-text entities

- **Genes:** CCL19 (C-C motif chemokine ligand 19) [NCBI Gene 6363] {aka CKb11, ELC, MIP-3b, MIP3B, SCYA19}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}
- **Diseases:** MPA (MESH:D055953), GPA (MESH:D014890)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11018871/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11018871/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC11018871/full.md

---
Source: https://tomesphere.com/paper/PMC11018871